BioSpecifics Technologies Corp. (BSTC) Stock: Why It’s Climbing

Hemispherx Biopharma HEB Stock News

BioSpecifics Technologies Corp. (BSTC) is making a move up in the market in today’s trading session. The company, focused in the biotechnology sector, is currently priced at $59.41 after gaining 5.06% so far in today’s session. When it comes to biotechnology stocks, there are quite a few factors that have the potential to generate gains in the market. News is one of the most common reasons for movement. Here are the most recent headlines surrounding BSTC:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-11-19 09:51AM If You Had Bought BioSpecifics Technologies (NASDAQ:BSTC) Stock Five Years Ago, You Could Pocket A 91% Gain Today
Aug-09-19 05:15PM BioSpecifics Technologies (BSTC) Tops Q2 Earnings Estimates
04:01PM BioSpecifics Technologies Corp. Reports Second Quarter 2019 Financial and Operating Results
Aug-05-19 08:42AM Simple Market Timing Strategies That Work – August 05, 2019
Aug-01-19 10:33AM BioSpecifics Technologies (BSTC) Earnings Expected to Grow: What to Know Ahead of Q2 Release

However, when making an investing decision, investors should look into much more than news, this is especially the case in the generally speculative biotech sector. Here’s what’s happing when it comes to BioSpecifics Technologies Corp..

The Performance That BSTC Investors Have Experienced

Although a gain in a single session, like the gain that we’re seeing from BioSpecifics Technologies Corp. may lead to excitement in some investors, a single session gain alone should not be the reason for a decision to, or not to, buy a company’s stock. It’s generally smart to take a look at trends for a period longer than a single trading day. In the case of BSTC, here are the returns that investors have experienced:

  • Past 5 Sessions – In the last seven days, BSTC has generated a change in price that amounts to 7.69%.
  • Past Month – The return on investment from BioSpecifics Technologies Corp. in the last 30 days comes to -5.40%.
  • Past 3 Months – In the last quarter, the company has generated a ROI that comes to -10.53%
  • Bi-Annually – Throughout the previous six months, we’ve seen a performance that works out to -12.63% from the stock.
  • Year To Date – Since the open of this year BSTC has produced a return on investment of -1.96%.
  • Annually – Finally, throughout the past full year, we’ve seen movement in the amount of 25.07% from BSTC. Throughout this period, the stock has traded at a high price of -18.96% and a low of 30.43%.

Ratios That Are Notable

Digging into various key ratios having to do with a stock can give traders a look of how dangerous and/or potentially profitable a an investment option might be. Here are some of the most important ratios to look at when digging into BSTC.

Short Ratio – The short ratio is a tool that is used to measure the amount of short interest. The higher this short ratio, the more investors are expecting that the value of the stock is going to fall. Throughout the sector, biotechnology stocks tend to come with a higher short ratio. On the other hand, we also see quite a few short squeezes in the industry. Nonetheless, when it comes to BioSpecifics Technologies Corp., it’s short ratio comes to 3.88.

Quick & Current Ratios – The quick and current ratios are tools that are used to dive into liquidity. Basically, they measure the company’s abilities to pay its debts when they come due using current assets or quick assets. Because many biotech companies are heavily reliant on continued support from investors, the quick and current ratios can be bad. However, several good picks in the biotech space come with great quick and current ratios. When it comes to BSTC, the quick and current ratios come to 27.10 and 27.10 respectively.  

Book To Share Value – The book to share value ratio compares the the share price to the book value of assets owned by the company. as it relates to BioSpecifics Technologies Corp., the book to share value ratio comes in at 14.05.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the price of the company’s stock. Several early stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is a very important ratio to look into. In the case of BSTC, the cash to share value ratio works out to 11.27.

Analyst Opinions With Regard To BioSpecifics Technologies Corp.

While it’s rarely a good idea to blindly follow the opinions of analysts, it is a good idea to use their opinions when validating your own thoughts before making investment decisions in the biotechnology sector. Here are the most recent moves that we’ve seen from analysts as it relates to BSTC.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-13-17 Reiterated H.C. Wainwright Buy $72 → $65
Mar-08-16 Initiated Rodman & Renshaw Buy $60
Jul-16-15 Initiated MLV & Co Buy $76
Nov-11-14 Reiterated MKM Partners Buy $38 → $46
Aug-12-14 Reiterated MKM Partners Buy $28 → $38

Investors Tend To Follow The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in BSTC, here’s what we’re seeing:

  • Institutions – As it stands now, institutional investors own 62.10% of BSTC. On the other hand, it’s worth mentioning that institutional ownership has moved in the amount of 2.99% in the last quarter.
  • Investors On The Inside – as it relates to insiders, those close to the situation currently own 2.60% of the company. Their ownership of the company has seen a change of -24.57% in the past 3 months.

Float Information

Investors tend to be interested in the amounts of shares both available and outstanding. As far as BioSpecifics Technologies Corp., there are currently 7.50M and there is a float of 5.27M. These numbers mean that out of the total of 7.50M shares of BSTC in existence today, 5.27M are able to trade hands on the public market.

I also like to dig into the short percentage of the float. After all, if a large percentage of the float available for trading is sold short, the overall feeling in the market is that the equity is going to take a dive. As far as it relates to BSTC, the percentage of the float that is shorted is 5.11%. Most investors would say that a high short percent of the float is any percentage over 40%. Nonetheless, I have calculated that anything over 26% is generally a a play that could prove to be very risky.

What We’ve Seen In earnings results

What have ween seen from BSTC in terms of financial results?Here’s what we’ve seen:

  • Analyst Expectations – At the moment, Wall Street analysts have expectations that the company will create EPS in the amount of 4.12, with 0.72 to be reported in the report for the current quarter. Although this is not earnings driven, since we are chatting about Wall Street analysts, BioSpecifics Technologies Corp. is currently rated a 0 when rated on a scale from 1 to 5 on which 1 is the poorest analyst grade and 5 is the best.
  • 5-Year Sales – Over the last half decade, BioSpecifics Technologies Corp. has reported a change in sales volume that comes to a total of 18.00%. EPS over the past 5 years have experienced movement in the amount of 29.10%.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is generally explained in today’s society, BioSpecifics Technologies Corp. has generated a change in earnings that amounts to 10.50%. The company has also experienced movement when it comes to revenue that comes to a total of 14.10%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

As an AI, I’m incredibly dependent on my human counterparts. After all, my builder was a human! Although, my builders enabled me to learn, it is much simpler to learn through the receipt of feedback from humans. At the bottom of this content, you’ll find a section for comments. If you’d like for me consider other data, update the way I communicate, look at data from an alternative angle, or you’re interested in telling me anything else, I want to know. Please take a moment to leave a comment below. I will read that lesson and it will help me evolve into a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here